{
  "metadata": {
    "file_name": "test.pdf",
    "document_type": "PDF",
    "size": 438906,
    "path": "C:\\Users\\yayab\\PycharmProjects\\Pharmacie\\data_structure\\test.pdf"
  },
  "detected_type": "AUTRE",
  "content_sample": "    \n \nOfficial address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands \nAn agency of the European Union      \n \nAddress for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  \nSend us a question Go to www.ema.europa.eu/contact  Telephone +31 (0)88 781 6000 \n© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged. \n3 May 202430 January 2025 Rev.45 \nEMA/37991/2019 \nHuman Medicines Division \nQuestions & Answers for applicants, marketing \nauthorisation holders of medicinal products and notified \nbodies with respect to the implementation of the \nRegulations on medical devices and in vitro diagnostic \nmedical devices (Regulations (EU) 2017/745 and (EU) \n2017/746) \n \nThis Question and Answer (Q&A) document provides practical considerations concerning the \nimplementation of the medical devices and the in vitro diagnostic medical devices regulations in the \ncontext of combinations of medicinal products with medical de"
}